Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,108
archived clinical trials in
Lupus

Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  7/31/2013
Clinical Research Facility
mi
from
Dallas, TX
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 7/31/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184
A Two-part Healthy Volunteer Study to Investigate Both the Interaction of GSK2586184 With Rosuvastatin and Simvastatin and to Compare the Pharmacokinetics of Two Different Formulations of GSK2586184
Status: Enrolling
Updated:  10/10/2013
GSK Investigational Site
mi
from
Baltimore, MD
A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184
A Two-part Healthy Volunteer Study to Investigate Both the Interaction of GSK2586184 With Rosuvastatin and Simvastatin and to Compare the Pharmacokinetics of Two Different Formulations of GSK2586184
Status: Enrolling
Updated: 10/10/2013
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated:  10/11/2013
Pfizer Investigational Site
mi
from
Alabaster, AL
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated: 10/11/2013
Pfizer Investigational Site
mi
from
Alabaster, AL
Click here to add this to my saved trials
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated:  10/11/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated: 10/11/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated:  10/11/2013
Pfizer Investigational Site
mi
from
Atlantis, FL
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated: 10/11/2013
Pfizer Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated:  10/11/2013
Pfizer Investigational Site
mi
from
Bloomingdale, IL
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated: 10/11/2013
Pfizer Investigational Site
mi
from
Bloomingdale, IL
Click here to add this to my saved trials
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated:  10/11/2013
Pfizer Investigational Site
mi
from
Avon, IN
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated: 10/11/2013
Pfizer Investigational Site
mi
from
Avon, IN
Click here to add this to my saved trials
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated:  10/11/2013
Pfizer Investigational Site
mi
from
Detroit, MI
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated: 10/11/2013
Pfizer Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated:  10/11/2013
Pfizer Investigational Site
mi
from
Asheville, NC
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated: 10/11/2013
Pfizer Investigational Site
mi
from
Asheville, NC
Click here to add this to my saved trials
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated:  10/11/2013
Pfizer Investigational Site
mi
from
Pittsburgh, PA
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated: 10/11/2013
Pfizer Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated:  10/11/2013
Pfizer Investigational Site
mi
from
Aberdeen, SD
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated: 10/11/2013
Pfizer Investigational Site
mi
from
Aberdeen, SD
Click here to add this to my saved trials
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated:  10/11/2013
Pfizer Investigational Site
mi
from
Bristol, TN
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated: 10/11/2013
Pfizer Investigational Site
mi
from
Bristol, TN
Click here to add this to my saved trials
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated:  10/11/2013
Pfizer Investigational Site
mi
from
Houston, TX
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated: 10/11/2013
Pfizer Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated:  10/11/2013
Pfizer Investigational Site
mi
from
Burke, VA
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated: 10/11/2013
Pfizer Investigational Site
mi
from
Burke, VA
Click here to add this to my saved trials
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated:  10/11/2013
Pfizer Investigational Site
mi
from
Beckley, WV
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
A Randomized, Subject And Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Preliminary Efficacy Of Multiple Ascending Doses Of PD- 0360324 In Subjects With Active Cutaneous Lupus Erythematosus (CLE)
Status: Enrolling
Updated: 10/11/2013
Pfizer Investigational Site
mi
from
Beckley, WV
Click here to add this to my saved trials
A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects
A Randomized, Parallel-Group, Open-Label Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Administered Subcutaneously to Healthy Subjects by Prefilled Syringe or Autoinjector
Status: Enrolling
Updated:  11/7/2013
GSK Investigational Site
mi
from
Overland Park, KA
A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects
A Randomized, Parallel-Group, Open-Label Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Administered Subcutaneously to Healthy Subjects by Prefilled Syringe or Autoinjector
Status: Enrolling
Updated: 11/7/2013
GSK Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
Danbury, CT
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
Kansas City, KA
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
Manhasset, NY
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
Manhasset, NY
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
New York, NY
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
Duncansville, PA
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
Amarillo, TX
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
Amarillo, TX
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated:  12/11/2013
Clinical Research Facility
mi
from
Dallas, TX
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Status: Enrolling
Updated: 12/11/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated:  1/6/2014
Southwest Shoulder, Elbow and Hand Center
mi
from
Tucson, AZ
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated: 1/6/2014
Southwest Shoulder, Elbow and Hand Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated:  1/6/2014
Bloomington Bone and Joint Clinic
mi
from
Bloomington, IN
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated: 1/6/2014
Bloomington Bone and Joint Clinic
mi
from
Bloomington, IN
Click here to add this to my saved trials
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated:  1/6/2014
Reconstructive Hand Surgeons of Indiana
mi
from
Carmel, IN
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated: 1/6/2014
Reconstructive Hand Surgeons of Indiana
mi
from
Carmel, IN
Click here to add this to my saved trials
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated:  1/6/2014
Indiana Hand Center
mi
from
Indianapolis, IN
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated: 1/6/2014
Indiana Hand Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated:  1/6/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated: 1/6/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated:  1/6/2014
The Center
mi
from
Bend, OR
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated: 1/6/2014
The Center
mi
from
Bend, OR
Click here to add this to my saved trials
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated:  1/6/2014
Fondren Orthopedic Group
mi
from
Houston, TX
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated: 1/6/2014
Fondren Orthopedic Group
mi
from
Houston, TX
Click here to add this to my saved trials
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated:  1/6/2014
Park Plaza Hospital and Medical Center
mi
from
Houston, TX
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated: 1/6/2014
Park Plaza Hospital and Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated:  1/6/2014
Hand Center of San Antonio
mi
from
San Antonio, TX
Ascension® MCP Post-Approval Study
Ascension® MCP Finger Implant Post-Approval Study
Status: Enrolling
Updated: 1/6/2014
Hand Center of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Functional MRI in Lupus Nephritis
Noninvasive Assessment Of Renal Activity And Damage Using Renal Functional MRI In Normal Healthy Volunteers And Subjects With Lupus Nephritis
Status: Enrolling
Updated:  1/31/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Functional MRI in Lupus Nephritis
Noninvasive Assessment Of Renal Activity And Damage Using Renal Functional MRI In Normal Healthy Volunteers And Subjects With Lupus Nephritis
Status: Enrolling
Updated: 1/31/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Functional MRI in Lupus Nephritis
Noninvasive Assessment Of Renal Activity And Damage Using Renal Functional MRI In Normal Healthy Volunteers And Subjects With Lupus Nephritis
Status: Enrolling
Updated:  1/31/2014
Clinical Research Facility
mi
from
New York, NY
Functional MRI in Lupus Nephritis
Noninvasive Assessment Of Renal Activity And Damage Using Renal Functional MRI In Normal Healthy Volunteers And Subjects With Lupus Nephritis
Status: Enrolling
Updated: 1/31/2014
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Functional MRI in Lupus Nephritis
Noninvasive Assessment Of Renal Activity And Damage Using Renal Functional MRI In Normal Healthy Volunteers And Subjects With Lupus Nephritis
Status: Enrolling
Updated:  1/31/2014
Clinical Research Facility
mi
from
Columbus, OH
Functional MRI in Lupus Nephritis
Noninvasive Assessment Of Renal Activity And Damage Using Renal Functional MRI In Normal Healthy Volunteers And Subjects With Lupus Nephritis
Status: Enrolling
Updated: 1/31/2014
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
A Non-drug Study Profiling Cutaneous Lupus
Cross-Sectional Study in Subjects With Active Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  8/12/2014
Clinical Research Facility
mi
from
Indianapolis, IN
A Non-drug Study Profiling Cutaneous Lupus
Cross-Sectional Study in Subjects With Active Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 8/12/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Non-drug Study Profiling Cutaneous Lupus
Cross-Sectional Study in Subjects With Active Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  8/12/2014
Clinical Research Facility
mi
from
Dallas, TX
A Non-drug Study Profiling Cutaneous Lupus
Cross-Sectional Study in Subjects With Active Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 8/12/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Pilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE)
Pilot Study in Children With Systemic Lupus Erythematosus (SLE) to Assess Flares and to Measure Traditional and Novel Blood Biomarkers and Antibody Titers Following Receipt of Inactivated Influenza Vaccine (IIV)
Status: Enrolling
Updated:  3/3/2015
Baylor Institute of Immunology Research
mi
from
Dallas, TX
Pilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE)
Pilot Study in Children With Systemic Lupus Erythematosus (SLE) to Assess Flares and to Measure Traditional and Novel Blood Biomarkers and Antibody Titers Following Receipt of Inactivated Influenza Vaccine (IIV)
Status: Enrolling
Updated: 3/3/2015
Baylor Institute of Immunology Research
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Birmingham, AL
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
La Jolla, CA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Long Beach, CA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Palm Desert, CA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Palm Desert, CA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
San Leandro, CA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
San Leandro, CA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Upland, CA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Upland, CA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Miami, FL
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Ocala, FL
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Orlando, FL
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Palm Harbor, FL
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Palm Harbor, FL
Click here to add this to my saved trials